vimarsana.com
Home
Live Updates
Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration : vimarsana.com
Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
Two-year extension for research and development of alpha-beta T cell medicines for the treatment of cancer and autoimmune diseasesCAMBRIDGE, Mass., May 01, 2024 -- Editas Medicine, Inc. , a...
Related Keywords
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Celgene Bristol Myers Squibb ,
Bristol Myers Squibb ,
Lindac Burkly ,
Broad Institute Cas ,
Exchange Commission ,
Editas Medicine Inc ,
Juno Therapeutics Inc ,
Harvard University Cas ,
Broad Institute ,
Nasdaq ,
Myers Squibb ,
Chief Scientific ,
Editas Medicine ,
Juno Therapeutics ,
Harvard University ,
Private Securities Litigation Reform Act ,
Annual Report ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.